Works matching AU Rastegar, Hossein


Results: 56
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno[2,3‐b]Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents.

    Published in:
    ChemistrySelect, 2022, v. 7, n. 44, p. 1, doi. 10.1002/slct.202104482
    By:
    • Mohammadi‐Khanaposhtani, Maryam;
    • Noori, Milad;
    • Valizadeh, Yousef;
    • Dastyafteh, Navid;
    • Ghomi, Minoo Khalili;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Hosseini, Samanesadat;
    • Biglar, Mahmood;
    • Larijani, Bagher;
    • Rastegar, Hossein;
    • Hamedifar, Haleh;
    • Mirzazadeh, Roghieh;
    • Mahdavi, Mohammad
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    New phenylthiosemicarbazide‐phenoxy‐1,2,3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes.

    Published in:
    Archiv der Pharmazie, 2024, v. 357, n. 7, p. 1, doi. 10.1002/ardp.202300517
    By:
    • Ansariashlaghi, Shirin;
    • Fakhrioliaei, Azadeh;
    • Mohammadi‐Khanaposhtani, Maryam;
    • Noori, Milad;
    • Asadi, Mehdi;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad A.;
    • Esfahani, Ensieh N.;
    • Rastegar, Hossein;
    • Larijani, Bagher;
    • Azizian, Homa;
    • Mahdavi, Mohammad
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29

    Design, synthesis, biological evaluation, and docking study of new acridine‐9‐carboxamide linked to 1,2,3‐triazole derivatives as antidiabetic agents targeting α‐glucosidase.

    Published in:
    Journal of Heterocyclic Chemistry, 2020, v. 57, n. 12, p. 4348, doi. 10.1002/jhet.4142
    By:
    • Asgari, Mohammad S.;
    • Tahmasebi, Behnam;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad A.;
    • Rahimi, Rahmatollah;
    • Ranjbar, Parviz R.;
    • Biglar, Mahmood;
    • Larijani, Bagher;
    • Rastegar, Hossein;
    • Mohammadi‐Khanaposhtani, Maryam;
    • Mahdavi, Mohammad
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18896-0
    By:
    • Azizian, Homa;
    • Pedrood, Keyvan;
    • Moazzam, Ali;
    • Valizadeh, Yousef;
    • Khavaninzadeh, Kimia;
    • Zamani, Ali;
    • Mohammadi-Khanaposhtani, Maryam;
    • Mojtabavi, Somayeh;
    • Faramarzi, Mohammad Ali;
    • Hosseini, Samanesadat;
    • Sarrafi, Yaghoub;
    • Adibi, Hossein;
    • Larijani, Bagher;
    • Rastegar, Hossein;
    • Mahdavi, Mohammad
    Publication type:
    Article
    43
    44
    45
    46

    Comparison of UVA Protection Factor Measurement Protocols.

    Published in:
    Clinical, Cosmetic & Investigational Dermatology, 2020, v. 13, p. 351, doi. 10.2147/CCID.S244898
    By:
    • Hedayat, Kamand;
    • Nasrollahi, Saman Ahmad;
    • Firooz, Alireza;
    • Rastegar, Hossein;
    • Dadgarnejad, Manouchehr
    Publication type:
    Article
    47
    48
    49

    Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.

    Published in:
    Molecular Diversity, 2021, v. 25, n. 2, p. 877, doi. 10.1007/s11030-020-10072-8
    By:
    • Asgari, Mohammad Sadegh;
    • Mohammadi-Khanaposhtani, Maryam;
    • Sharafi, Zeinab;
    • Faramarzi, Mohammad Ali;
    • Rastegar, Hossein;
    • Nasli Esfahani, Ensieh;
    • Bandarian, Fatemeh;
    • Ranjbar Rashidi, Parviz;
    • Rahimi, Rahmatollah;
    • Biglar, Mahmood;
    • Mahdavi, Mohammad;
    • Larijani, Bagher
    Publication type:
    Article
    50